Shanghai Haohai Biological Technology Co Ltd - ESG Rating & Company Profile powered by AI
Other companies in the rating peer group for Shanghai Haohai Biological Technology Co Ltd are shown. This ESG score covers 17 United Nations SDGs including: 'Good Health & Wellbeing', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'. This Sustainability assessment for Shanghai Haohai Biological Technology Co Ltd represents its transparency towards the United Nations Sustainable Development Goals.
Shanghai Haohai Biological Technology Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Shanghai Haohai Biological Technology Co Ltd | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Shanghai Haohai Biological Technology Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Shanghai Haohai Biological Technology Co Ltd disclose current and historical energy intensity?
Does Shanghai Haohai Biological Technology Co Ltd report the average age of the workforce?
Does Shanghai Haohai Biological Technology Co Ltd reference operational or capital allocation in relation to climate change?
Does Shanghai Haohai Biological Technology Co Ltd disclose its ethnicity pay gap?
Does Shanghai Haohai Biological Technology Co Ltd disclose cybersecurity risks?
Does Shanghai Haohai Biological Technology Co Ltd offer flexible work?
Does Shanghai Haohai Biological Technology Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Shanghai Haohai Biological Technology Co Ltd disclose the number of employees in R&D functions?
Does Shanghai Haohai Biological Technology Co Ltd conduct supply chain audits?
Does Shanghai Haohai Biological Technology Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Shanghai Haohai Biological Technology Co Ltd conduct 360 degree staff reviews?
Does Shanghai Haohai Biological Technology Co Ltd disclose the individual responsible for D&I?
Does Shanghai Haohai Biological Technology Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Shanghai Haohai Biological Technology Co Ltd disclose current and / or historical scope 2 emissions?
Does Shanghai Haohai Biological Technology Co Ltd disclose water use targets?
Does Shanghai Haohai Biological Technology Co Ltd have careers partnerships with academic institutions?
Did Shanghai Haohai Biological Technology Co Ltd have a product recall in the last two years?
Does Shanghai Haohai Biological Technology Co Ltd disclose incidents of discrimination?
Does Shanghai Haohai Biological Technology Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Shanghai Haohai Biological Technology Co Ltd issued a profit warning in the past 24 months?
Does Shanghai Haohai Biological Technology Co Ltd disclose parental leave metrics?
Does Shanghai Haohai Biological Technology Co Ltd disclose climate scenario or pathway analysis?
Does Shanghai Haohai Biological Technology Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Shanghai Haohai Biological Technology Co Ltd disclose the pay ratio of women to men?
Does Shanghai Haohai Biological Technology Co Ltd support suppliers with sustainability related research and development?
Does Shanghai Haohai Biological Technology Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Shanghai Haohai Biological Technology Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Shanghai Haohai Biological Technology Co Ltd involved in embryonic stem cell research?
Does Shanghai Haohai Biological Technology Co Ltd disclose GHG and Air Emissions intensity?
Does Shanghai Haohai Biological Technology Co Ltd disclose its waste policy?
Does Shanghai Haohai Biological Technology Co Ltd report according to TCFD requirements?
Does Shanghai Haohai Biological Technology Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Shanghai Haohai Biological Technology Co Ltd disclose energy use targets?
Does Shanghai Haohai Biological Technology Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Shanghai Haohai Biological Technology Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Shanghai Haohai Biological Technology Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, the United States, the United Kingdom, and internationally. The company offers ophthalmology, medical aesthetics and wound care, orthopedics, anti-adhesion, and homostasis products. It also provides medical sodium hyaluronate, medical chitosan, medical collagen sponge, and recombinant human epidermal growth factor (rhEGF), as well as biological reagents and materials. In addition, the company engages in the manufacture and sale of contact lens and intraocular lens materials, machines, and accessories; and investment and trading businesses. Further, it is involved in research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.